Dictionary

allow_url_fopen is ENABLED Dictionary Search

retinitis

Synonyms

Noun

1. inflammation

2. redness, rubor

Usage
Intravitreal photoswitch therapy in advanced retinitis pigmentosa: a phase 1 open-label trial - Nature
ARVO 2026: Gene therapy and optogenetics show lasting vision improvement in retinitis pigmentosa - Ophthalmology Times
Retinitis Pigmentosa Market Unlocking New Revenue Opportunities and Strategic Expansion by 2034 – DelveInsight | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics, 4D Molecular Therap - Barchart.com
This eye disorder is ‘among leading causes of blindness in younger individuals’: Know more - The Indian Express
New gene therapies offer a universal approach to treating retinitis pigmentosa - Drug Discovery News
RGR-Mediated Photopic Visual Cycle and Oxidative Stress: Potential Mechanisms for Cone Vision Impairment and Retinal Degeneration in Retinitis Pigmentosa Linked to D1080N-IRBP - Journal of Neuroscience
MCO-010 improves vision in patients with retinitis pigmentosa at 3 years - Healio
Stargardt Disease Presenting as Retinitis Pigmentosa: A Case of Monoallelic ABCA4-Associated Retinopathy - Cureus
Visual acuities in patients with autosomal recessive retinitis pigmentosa associated with four rod phototransduction genes - Nature
FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa - Ophthalmology Times
Deep learning detection of retinitis pigmentosa inheritance forms through synthetic data expansion of a rare disease dataset - Nature
FDA grants orphan drug designation to DSP-3077 for retinitis pigmentosa - Ophthalmology Times
De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa - Nature
Ocugen completes enrollment in liMeliGhT phase 3 trial of OCU400 for retinitis pigmentosa - Ophthalmology Times
PRPF8-associated retinitis pigmentosa variant induces human neural retina-autonomous photoreceptor defects - Nature
Prevalence and Risk Factors for Cytomegalovirus Retinitis Among People Living with HIV in Sub-Saharan Africa in the Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis - Nature
Leveraging large scale deep learning models for diagnosis and visual outcome prediction in retinitis pigmentosa - Nature
Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response - Nature
Phenotypic features of EYS -associated retinitis pigmentosa with the c.2528 G > A (p.Gly843Glu) mutation in a Japanese cohort - Nature
Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trials - Ophthalmology Times Europe
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa - Ophthalmology Times
A New Rising Professorship Targets Retinitis Pigmentosa - Johns Hopkins Medicine
Early Onset Cataract, Retinal Detachment Risk Higher With Retinitis Pigmentosa - Ophthalmology Advisor
SparingVision begins dosing patients with retinitis pigmentosa in NYRVANA clinical trial - Ophthalmology Times Europe
Editorial: Retinitis pigmentosa, macular degeneration and related diseases - Frontiers
Laru-zova sustains visual function improvements at 12 months in XLRP gene therapy trial - Ophthalmology Times
Cis‐ and Trans‐Regulatory Factors Independently Shape Phenotypic Heterogeneity of Retinitis Pigmentosa - Wiley
Restore Vision Reports Early Clinical Signal for GPCR-Based Optogenetic Therapy in Retinitis Pigmentosa - BioPharm International
Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa - Ocugen, Inc.
Q&A: Christine Kay on the REMAIN trial results for patients with retinitis pigmentosa - Modern Retina
No significant visual gains seen with PDE6A gene supplementation in early-phase trial - Ophthalmology Times
AAV-mediated gene replacement therapy for LRAT -associated retinitis pigmentosa: a proof-of-concept study in a patient-based rat model - Nature
Restore Vision Reports Encouraging Phase I II Data For RV 001 Gene Therapy In Retinitis Pigmentosa - BioPharma APAC
Ray Therapeutics Granted Priority Medicines (PRIME) Designation from the European Medicines Agency for RTx-015 in Retinitis Pigmentosa - Business Wire
EyeWorld Weekly, February 13, 2026 - EyeWorld
A self-supervised learning method for detection of retinitis pigmentosa and Stargardt disease - Nature
ARVO 2026: Optogenetic REMAIN 3 year study data - Ophthalmology Times
Microaneurysms in HIV-negative cytomegalovirus retinitis: an uncommon finding - Nature
Application of smooth OWA operators to classification of retinitis pigmentosa - Nature
Subtenon WJ-MSC Therapy for Retinitis Pigmentosa Insights - European Society of Medicine
Non-coding RNA mutations unveiled as new cause of retinitis pigmentosa - News-Medical
Nanoscope Nabs RMAT Designation for Retinitis Pigmentosa Gene Therapy MCO-010 - CGTLive®
Unilateral Retinitis Pigmentosa, Glial Tissue Abnormality, and Microphthalmia in a Young Female Patient: A Case Report - Cureus
Gene-Agnostic Therapy Sees 3-Year Gain in Severe Vision Loss - Medscape
Wharton’s Jelly Stem Cells in Retinitis Pigmentosa: Safety & Outcomes - European Society of Medicine
Retinitis pigmentosa mouse models reflect pathobiology of human RP59 - The University of Alabama at Birmingham
Christine Kay, MD, on the 152-week results of the RESTORE study for retinitis pigmentosa - Ophthalmology Times
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa - Yahoo Finance
Nanoscope’s gene therapy, MCO-010 receives Sakigake and Orphan Drug Designations in Japan - Ophthalmology Times
Zhongmou Therapeutics’ RP gene therapy shows promise in first-in-human trial - Clinical Trials Arena
Genome-wide screen yields new gene therapies to protect against retinal degeneration - Medical Xpress
Light in the dark: the search for new treatments for hereditary blindness - The Conversation
Nanoscope Therapeutics Announces Durable 3-Year Vision Improvements from REMAIN Study of MCO-010 in Retinitis Pigmentosa - PR Newswire
Preventing light-induced toxicity in a new mouse model of sector retinitis pigmentosa caused by Rhodopsin M39R variant - Nature
SparingVision completes PRODYGY trial patient dosing with SPVN06 - Ophthalmology Times
Severe cytomegalovirus retinitis - Nature
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway - TMX Newsfile
Mutation-Agnostic Gene Therapy May Restore Vision in RP - Medscape
Ray Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RTx-015 in Retinitis Pigmentosa - Business Wire
Ocugen Completes Enrollment in OCU400 Phase 3 Clinical Trial for Retinitis Pigmentosa, Prepares for Major 2027 Data Announcements - Quiver Quantitative
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa - GlobeNewswire
Intravitreal Methotrexate Fast Tracked for Retinitis Pigmentosa - Ophthalmology Advisor
Nanoscope Announces Groundbreaking 3-Year REMAIN Trial Data for Patients with Retinitis Pigmentosa at 2025 Euretina Congress and Retina Society Annual Scientific Meeting - PR Newswire
Nanoscope Therapeutics Post-Hoc Clinical Analyses to be Presented at 2026 Macula Society Annual Meeting - PR Newswire
Transplanted neural stem cells help preserve vision in retinal degeneration - Medical Xpress
New tech surgery aids recovery of vision - China Daily - Global Edition
EyeWorld Weekly, November 7, 2025 - EyeWorld
Nanoscope Therapeutics releases positive 3-year follow-up data from REMAIN study - Ophthalmology Times
Retinitis Pigmentosa-Associated Gene TRIM49 Regulates ULK1-Mediated Autophagy and Photoreceptor Phagocytosis by the Retinal Pigment Epithelium - Wiley
A New Era For Blindness Treatment Is Within Sight - Forbes
Case Report: Effective management of acute corneal hydrops with concurrent nystagmus and retinitis pigmentosa: combination of deep lamellar corneal suturing and anterior chamber gas injection - Frontiers
12 gene therapies converge on retinitis pigmentosa and a $3.4bn market by 2033 - Cambridge Network
Vision Rescued: How Stem Cells "Rehabilitate" the Dying Eye - Neuroscience News
Beacon Therapeutics announces positive topline data from DAWN and SKYLINE trials - Modern Retina
Nanoscope Therapeutics Puts Rolling BLA for Retinitis Pigmentosa Gene Therapy MCO-010 in Front of FDA - CGTLive®
Gene Therapy Shows Signal for Improving Retinal Function - Medscape
FDA clears Zhongmou Therapeutics' IND for RP optogenetic gene therapy - Eyes On Eyecare
Retinal dystrophies: gene-agnostic therapy based on miRNAs - Ricerca Malattie Genetiche Rare
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea - Ocugen, Inc.
MCO-010 shows long-term safety, quality of life improvements in retinitis pigmentosa - Healio
Bispecific antibody therapy-associated opportunistic infections: cytomegalovirus retinitis and chronic salmonellosis in a non-HIV patient - Haematologica
Potential one-time RP gene therapy moves closer as Ocugen fills major trial - Stock Titan
A case of non-necrotising herpetic retinitis - Elsevier
Pigment Pathways Collide: A Rare Case of Retinitis Pigmentosa and Nevus of Ota - Cureus
Study links female sex hormones to progression of eye disease: Newsroom - UT Southwestern Medical Center
Neural Stem Cell Therapy Shows Promise in Preserving Vision in Retinitis Pigmentosa - The Indian Practitioner
Opus Genetics Launches First Clinical Trial for MERTK-Related RP Gene Therapy - Eyewire+
Cytomegalovirus necrotizing retinitis in an immunocompetent patient: A case report - Elsevier
Internal limiting membrane drape sign in toxoplasma retinitis - Eye - Nature
Scientists find new genetic causes of sight loss that could provide answers for thousands of patients - genomicsengland.co.uk
Genetic study uncovers unknown causes of blindness - Medical Xpress
AviadoBio secures option to rare eye disease gene therapy that could bring Chinese biotech $413M - Fierce Biotech
Comprehensive Rehabilitation for Autosomal Dominant Retinitis Pigmentosa: A Case Report - Wiley Online Library
jCyte Inc. Announces First Patients Treated in JC02-88 Trial for Retinitis Pigmentosa - Business Wire
AI Tool Shows Acetazolamide Reduces Intraretinal Fluid in Retinitis Pigmentosa Edema - Ophthalmology Advisor
Australian biotech firm Mirugen secures major funding for cell reprogramming therapy - Ophthalmology Times Europe
New gene therapy trial targets rare blindness in 60,000 people - Stock Titan
EyeWorld Weekly, July 18, 2025 - EyeWorld
Durable efficacy, safety seen at 3 years for MCO-010 gene therapy in retinitis pigmentosa - Healio
‘Love Is Blind’ Season 9: What Is Madison Maidenberg’s Diagnosis? - Cosmopolitan
Foreign Language Equivalents
Foreign Language Equivalents of 'retinitis'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
reinitis,   reetinitis,   ertinitis,   retinitid,   tetinitis,   retinitiss,   rrtinitis,   reyinitis,   retiintis,   retinnitis,   rretinitis,   retinitiis,   retinotis,   retinits,   rwtinitis,   retibitis,   retiniti,   retiniis,   retimitis,   retinittis,   rerinitis,   reitnitis,   retintis,   retinitos,   retiitis,   retiinitis,   retinitia,   retiniitis,   retiniyis,   retinitus,   retinitsi,   eetinitis,   rtinitis,   rettinitis,   retiniris,   rteinitis,   retunitis,   retnitis,   retiniits,   retonitis,   retintiis,   etinitis,   retniitis,   retinutis
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z